Previous close | 96.23 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 141 |
Market cap | 11.452M |
Beta (5Y monthly) | 0.91 |
PE ratio (TTM) | 0.18 |
EPS (TTM) | 5.32 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LURE, France, March 20, 2024--Regulatory News: Vetoquinol (Paris:VETO):
LURE, France, January 24, 2024--Regulatory News: Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO), said: "In an animal health market with flat volumes, our 2023 sales reflect our company’s resilience and agility. Sales were driven by the strong performance of our Essentials products in the second half of the year; their sustained growth has enabled us to continue to improve our product mix and increase the efficiency of our operations. We are therefore actively pursuing the implemen
LURE, France, January 03, 2024--Regulatory News: Vetoquinol (Paris:VETO) published its calendar of financial communication for 2024.